Incannex Healthcare Inc.
$3.84
▼
-2.03%
2026-04-21 07:37:01
www.incannex.com
NCM: IXHL
Explore Incannex Healthcare Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$51 M
Current Price
$3.84
52W High / Low
$49.8 / $2.4
Stock P/E
—
Book Value
$6.13
Dividend Yield
—
ROCE
—
ROE
-1.3%
Face Value
—
EPS
$-24.39
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
12
Beta
2.73
Debt / Equity
0.22
Current Ratio
48.27
Quick Ratio
—
Forward P/E
-1.59
Price / Sales
—
Enterprise Value
$-31.47 M
EV / EBITDA
1.24
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bausch Health Companies Inc. | $5.91 | 14.05 | $3.02 B | — | 9.85% | 4.36% | $11.97 / $6.06 | $-1.5 |
| 2. | SIGA Technologies, Inc. | $4.57 | 14.06 | $327.41 M | 0% | 11.76% | 11.23% | $9.62 / $4.29 | $2.78 |
| 3. | Akebia Therapeutics, Inc. | $1.43 | — | $381.73 M | — | 11% | 64.49% | $4.08 / $1.14 | $0.12 |
| 4. | Rockwell Medical, Inc. | $0.94 | — | $37.03 M | — | -9.86% | -15.28% | $2.1 / $0.78 | $0.94 |
| 5. | Eton Pharmaceuticals, Inc. | $25.28 | — | $683.2 M | — | -1.57% | -18.19% | $27.29 / $13.09 | $0.97 |
| 6. | Esperion Therapeutics, Inc. | $2.02 | — | $510.15 M | — | 36.51% | 6.57% | $4.17 / $0.69 | $-1.23 |
| 7. | InterCure Ltd. | $0.75 | — | $125.93 M | — | -8.41% | -16.68% | $605 / $225.3 | $7.59 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | — | 0 M | 0.01 M | 0.07 M |
| Operating Profit | -6.51 M | -6.41 M | — | -4.58 M | -4.05 M | -5.44 M |
| Net Profit | -6.52 M | -6.41 M | — | -3.97 M | -5.89 M | -5.42 M |
| EPS in Rs | -0.47 | -0.46 | — | -0.28 | -0.42 | -0.39 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | — | 0.01 M | 0 M | 0 M |
| Operating Profit | — | -18.61 M | -13.64 M | -10.16 M |
| Net Profit | — | -18.46 M | -48.81 M | -10.25 M |
| EPS in Rs | -40.5 | -1.32 | -3.49 | -0.73 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | — | 17.05 M | 23.78 M | 26.06 M |
| Total Liabilities | — | 5.83 M | 2.96 M | 1.38 M |
| Equity | — | 11.22 M | 20.82 M | 24.67 M |
| Current Assets | — | 16.2 M | 23 M | 26.06 M |
| Current Liabilities | — | 5.62 M | 2.55 M | 1.38 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -15.85 M | -10.75 M | -8.81 M | -5.19 M |
| Investing CF | -0.28 M | -0.32 M | 0 M | 0.02 M |
| Financing CF | 0 M | 8.18 M | 28.33 M | 9.32 M |
| Free CF | -16.12 M | -11.06 M | -8.81 M | -5.19 M |
| Capex | -0.28 M | -0.32 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | -100% | — |
| Earnings Growth % | 62.18% | -376.09% | -19.99% | — |
| Profit Margin % | -153825% | — | — | -599.33% |
| Operating Margin % | -155058.33% | — | — | -601.34% |
| Gross Margin % | — | — | — | 51.94% |
| EBITDA Margin % | -152716.67% | — | — | -601.34% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-27 | 1:0.0333333 |